A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

Krarup, Anders, Truan, Daphné, Furmanova-Hollenstein, Polina, Bogaert, Lies, Bouchier, Pascale, Bisschop, Ilona J. M., Widjojoatmodjo, Myra N., Zahn, Roland +3 more·2015·Nature Communications
DOI 10.1038/ncomms9143

Cited by (384)

Items 301–384 of 384

  1. Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
    Jorge C. G. Blanco, Lori M. Cullen, Arash Kamali, Fatouomata Y. D. Sylla, Marina S. Boukhvalova, Trudy G. Morrison · 2023 · Viruses
  2. Respiratory Syncytial Virus in Children: A Comprehensive Review on Publication Trends, Epidemiology, Pathogenesis, Vaccines, and Prevention Strategies
    Sreedasyam Sreedevi, Gudikandula Krishna · 2024 · Infectious diseases
  3. Development and Validation of an Enzyme-Linked Immunosorbent Assay-Based Protocol for Evaluation of Respiratory Syncytial Virus Vaccines
    Eliel Nham, A-Yeung Jang, Hyun Jung Ji, Ki Bum Ahn, Joon‐Yong Bae, Man‐Seong Park, 현학준, Jin Gu Yoon, Hye Seong, Ji Yun Noh et al. · 2024 · Viruses
  4. AntigenBoost: enhanced mRNA-based antigen expression through rational amino acid substitution
    Gao Y, Siran Zhu, Hui‐Chun Li, Xueting Hao, Wen Chen, Deng Pan, Zhikang Qian · 2024 · Briefings in Bioinformatics
  5. Robust and Long-Lasting Immunity and Protection in Mice Induced by Lipopolyplex-Delivered mRNA Vaccines Expressing the Prefusion Protein of Respiratory Syncytial Virus
    Xuchang Shan, Ruiwen Han, Xueting Cheng, Jialuo Bing, Zhenyong Qi, Shucai Sun, Tangqi Wang, Qiaohong Chu, Yao Deng, Desheng Zhai et al. · 2025 · Vaccines
  6. System Theoretic Methods in Drug Discovery and Vaccine Formulation: Review and Perspectives
    Ankita Sharma, Yen-Che Hsiao, Abhishek Dutta · 2025 · Drugs and Drug Candidates
  7. Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency
    Mohamed A. Farrag, Haitham Mohamed Amer, Peter Öhlschläger, Maaweya E. Hamad, Fahad Nasser Almajhdi · 2017 · Human Vaccines & Immunotherapeutics
  8. The protective immunity induced by intranasally inoculated serotype 63 chimpanzee adenovirus vector expressing human respiratory syncytial virus prefusion fusion glycoprotein in BALB/c mice
    Lei Huang, Meiqing Liu, Chang-Qing Wan, Ningning Cheng, Yan-Bin Su, Yan-Peng Zheng, Xiang-Lei Peng, Jie‐mei Yu, Yuan-Hui Fu, Jinsheng He · 2022 · Frontiers in Microbiology
  9. THE GORDON WILSON LECTURE: RAPID COVID-19 VACCINE DEVELOPMENT AND THE FUTURE OF VACCINOLOGY.
    Barney S. Graham · 2023 · PubMed Central
  10. Innovation-driven trend shaping COVID-19 vaccine development in China
    Yuntao Zhang, Yuxiu Zhao, Hongyang Liang, Ying Ming Xu, Chuge Zhou, Yuzhu Yao, Hui Wang, Xiaoming Yang · 2023 · Frontiers of Medicine
  11. Rational design of next-generation filovirus vaccines through glycoprotein stabilization, nanoparticle display, and glycan modification
    Yi-Zong Lee, Yi-Nan Zhang, Maddy L. Newby, Garrett Ward, Keegan Braz Gomes, Sarah Auclair, Connor DesRoberts, Joel D. Allen, Andrew B. Ward, Robyn L. Stanfield et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  12. Position Paper on Road Map for RNA Virus Research in India
    Guruprasad R. Medigeshi, Katja Fink, Nagendra R. Hegde · 2018 · Frontiers in Microbiology
  13. Research progress on the vaccine of Epstein-Barr virus
    Zi‐Ying Jiang, XianShu TIAN, Chu XIE, Qian Zhong, Cong SUN, Mu‐Sheng Zeng · 2024 · Scientia Sinica Vitae
  14. Favorable Nonclinical Safety Profile of RSVpreF Bivalent Vaccine in Rats and Rabbits
    Jun Yu Zhou, Christopher Bowman, Vicki R. Markiewicz, Balasubramanian Manickam, Emily A. Gomme, Rani S. Sellers, Cynthia M. Rohde · 2024 · Vaccines
  15. Computational discovery of RSV Pre-F inhibitors via reinforcement learning-driven ab initio design from natural fragment libraries
    Shengpeng Wang, Yongzhu Zhao, Jiawei Li, Lifu Zhang, Fei Yan, Cuihong Wang, Liying Shi, Meiling Zhang, Meiling Zhang · 2025 · Computational Biology and Chemistry
  16. Virus-like particles containing the extracellular domain of G protein in combination with a CTL peptide of M2 elicit protection against respiratory syncytial virus infection without pulmonary disease
    Huan Qin, Jin Luo, Zishu Pan · 2025 · Frontiers in Immunology
  17. Age-specific antibody profiles of respiratory syncytial virus after COVID-19 pandemic: a sero-epidemiological survey in Taizhou City, Eastern China
    Bo Zheng, Qiang Wang, Kathy S. M. Leung, Hongbiao Liang, Weiwei Shen, Mengting Cao, Suyi Zhang, Ye Wu, Haijiang Lin, Weibing Wang · 2025 · BMC Infectious Diseases
  18. Serological evidence of substantial respiratory syncytial virus infection burden among older adults residing in Swedish long-term care facilities
    Preeti Moar, Christoffer Granvik, Kim Balaton Blom, Erick Bermúdez-Méndez, Florian A. Gegenfurtner, Julia Wigren Byström, Peter Fjällström, Mikael Åberg, Johan Normark, Karin Loré et al. · 2026 · BMC Medicine
  19. Conformational dynamics of SARS-CoV-2 spike on a membrane reveals the allosteric effects of furin cleavage and the D614G mutation
    Sophie R. Shoemaker, Megan Luo, Kim-Marie A. Dam, John E. Pak, Magnus A. G. Hoffmann, Susan Marqusee · 2026 · Science Advances
  20. AI-guided prefusion stabilization of the human coronavirus OC43 spike protein enables universal embecovirus antigen design
    Jelle M. Melchers, Jarek Juraszek, Ruben J. G. Hulswit, Daan van Overveld, Lam Le, Frank J. M. van Kuppeveld, Daniel L. Hurdiss, Berend‐Jan Bosch, Johannes P.M. Langedijk, Mark J. G. Bakkers · 2026 · PLoS Pathogens
  21. RNA therapeutics for infectious diseases
    Le Minh Tu Phan; Phan Le Minh Tu, Thi Thuy Duong Pham, Van Thai Than · 2024 · Progress in molecular biology and translational science
  22. Mammalian Antigen Display for Pandemic Countermeasures
    Andrea Quezada, Ankur Annapareddy, Kamyab Javanmardi, John Cooper, Ilya J. Finkelstein · 2024 · Methods in molecular biology
  23. A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model
    Jérémy Brunet, Zaineb Choucha, Marion Gransagne, Houda Tabbal, Min‐Wen Ku, Julian Buchrieser, Priyanka Fernandes, Damien Batalie, Jodie Lopez, Laurence Ma et al. · 2024 · Journal of Virology
  24. Development and evaluation of a recombinant monoclonal human antibody with virus-neutralizing activity against the F glycoprotein of respiratory syncytial virus
    Sergey A. Klotchenko, Ekaterina Romanovskaya-Romanko, Marina A. Plotnikova, Anastasia Pulkina, Aram A. Shaldzhyan, Балабашин Дмитрий Сергеевич, Victoria A. Toporova, Teimur K. Aliev, Natalia E. Gyulikhandanova, Dmitry A. Lioznov · 2024 · Journal of microbiology epidemiology immunobiology
  25. mRNA疗法的研究进展与挑战
    Jiayan Fu, Shuo Feng, Binhe Du, Haiyang Dong, Jinzhong Lin, Jin Yongfeng · 2021 · Scientia Sinica Vitae
  26. Respiratory Syncytial Virus
    José Antonio Melero, Alfonsina Trento, Vicente Más · 2017 · Encyclopedia of Life Sciences
  27. Efficacy and safety of an mRNA-based RSV preF vaccine in preclinical studies
    Huarong Bai, Qin Li, Yue Gao, yubin zhao, xueliang yu, Rongkuan Hu · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  28. Evaluation of Viral Diagnostics on rEspiratory iNfections in ChildrEn
    Jérôme O. Wishaupt · 2012
  29. Respiratory Syncytial Virus Fusion Protein Interaction with its Cellular Receptor, Nucleolin
    Daniel Zhu · 2018 · TSpace (University of Toronto)
  30. Magnitude of RSV Fusion Protein-Specific Antibodies in Infants and Corresponding Mothers
    Sara Taleb · 2018 · Qatar University QSpace (Qatar University)
  31. CHARACTERIZATION AND IMMUNOMODULATION OF THE INFANT IMMUNE RESPONSE TO RESPIRATORY SYNCYTIAL VIRUS
    Katherine Km Eichinger · 2019 · D-Scholarship@Pitt (University of Pittsburgh)
  32. Alveolar-Like Stem Cell-Derived Macrophages Protect Against RSV Induced Lung Damage
    Yuchen Cen · 2020 · TSpace (University of Toronto)
  33. Faculty Opinions recommendation of Induction of potent neutralizing antibody responses by a designed protein nanoparticle vaccine for respiratory syncytial virus.
    Shama Parveen · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  34. Faculty Opinions recommendation of A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus.
    Fernando P. Polack · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  35. Faculty Opinions recommendation of Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor.
    Mark Marsh · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  36. Faculty Opinions recommendation of Induction of potent neutralizing antibody responses by a designed protein nanoparticle vaccine for respiratory syncytial virus.
    Rino Rappuoli · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  37. Faculty Opinions recommendation of Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus.
    Fernando P. Polack · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  38. ANTI-VIRUS ACTION OF MEDICINAL PLANTS (LITERATURE REVIEW)
    Nadiia GORCHAKOVA, Yulia GUSEVA, Tatyana HARNYK, Stanislav VESELSKY, A. M. Doroshenko, Ella GOROVA · 2022 · Fìtoterapìâ
  39. A Poorest-First Approach to RSV Vaccine Development
    Natalie I Mazur · 2022
  40. Caught in the Act: targeted mutagenesis of the herpesvirus fusogen central helix captures transition states
    Momei Zhou, Benjamin Vollmer, Emily A. Machala, Muyuan Chen, Kay Grünewald, Ann M. Arvin, Wah Chiu, Stefan L. Oliver · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  41. We are all on the same team
    Annefleur C. Langedijk · 2023
  42. Pneumonia A Review based on Pathogenic Factors
    Cheng Lin, Baibai Ye, Ping Chen, Linfu Li · 2023 · Current Traditional Medicine
  43. Generation of novel respiratory syncytial virus vaccine candidate antigens that can induce high levels of prefusion-specific antibodies
    Rima Matsuyama, Tomoharu Hogiri, Hiroyuki Kishida, Kei Takedomi, Okimasa Okada, Akitoshi Nishizawa, Sakiko Higashi-Nakatani, Takeshi Ōmasa · 2024 · Journal of Bioscience and Bioengineering
  44. From nutritional support to innovative vaccines: Approaches to bolster the immune response to respiratory infection
    Suyeon Hong · 2024
  45. KD-409, a Respiratory Syncytial Virus FG Chimeric Protein without the CX3C Chemokine Motif, Is an Efficient Respiratory Syncytial Virus Vaccine Preparation for Passive and Active Immunization in Mice
    Ryo Yamaue, Masaharu Torikai, Madoka Terashima, Hiroaki Mori · 2024 · Vaccines
  46. Immune Response to Respiratory Syncytial Virus
    Hujaz Ismail Abdulrazzaq Alqirbi, Batool Mutar Mahdi, Mustafa Almukhtar · 2024 · Iraqi Journal of Community Medicine
  47. A Single Amino Acid Mutation Alters the Neutralization Epitopes in the Respiratory Syncytial Virus Fusion Glycoprotein
    Ahmed K. Oraby, Aleksandra Stojic, Farah Elawar, Leanne M. Bilawchuk, Ryley D. McClelland, Kaci Erwin, Madison J. Granoski, Cameron D. Griffiths, Justin D. Frederick, Elena I Arutyunova et al. · 2024 · Research Square
  48. Research progress on the structure of Epstein-Barr virus
    Ling ZHONG, YuFei WANG, Chengyu Yang, Yang Huang, Huiping He, Qingbing Zheng, Xiao ZHANG · 2024 · Scientia Sinica Vitae
  49. Development of a genetically modified full-length human respiratory syncytial virus preF protein vaccine
    Geqi Lao, Jin Feng, Liping Wu, Wenhan Su, Liyun Chen, Lejun Yang, Songchen Zhang, Yuhua Xu, Tao Peng · 2025 · Vaccine
  50. A bivalent mRNA vaccine against RSV infection in rodent models
    Juan Liu, Hanqing Zhao, Wenhao Wang, Bin Yang, Naifang Zhang, Yu Zhang, Jie Qian, Qiaofang Ma, Yankun Lu, Huafeng Han et al. · 2025 · Frontiers in Immunology
  51. Potent neutralization of Marburg virus by a vaccine-elicited monoclonal antibody
    Amin Addetia, Lisa Perruzza, Young‐Jun Park, Matthew McCallum, Cameron Stewart, Jack T Brown, Alessia Donati, Katja Culap, Alessio Balmelli, Michal Gaži et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  52. Stabilizing the Shield: C-Terminal Tail Mutation of HMPV F Protein for Enhanced Vaccine Design
    Reetesh Kumar, Subhomoi Borkotoky, Rohan Gupta, Jyoti Gupta, Somnath Maji, Savitri Tiwari, Rajeev Kumar Tyagi, Baldomero Oliva · 2025 · BioMedInformatics
  53. Stabilization of the trimeric pre-fusion structures of influenza H1 and H9 hemagglutinins by mutations in the stem helices
    Ga Young Lee, Yun Geun Kim, Shin Hc, Chang Jun Lee, Jie‐Oh Lee · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  54. Comparative Evaluation of Three Nanoparticle Vaccines Targeting the Prefusion F Protein of Respiratory Syncytial Virus: Immunogenicity and Protective Efficacy.
    Jie Jiang, Hongqiao Hu, Lei Cao, Naiying Mao, Zhen Zhu, Na Wang, Yuqing Shi, Li Hai, Yan Zhang · 2025 · PubMed Central
  55. Engineering mucosal immunity: Advanced vaccine platforms against respiratory pathogens
    Musi Wang, Qi Chang, Bowen Li, Run Yang, Xuheng Chen, Yang Bai, Huining He, Bin Zheng · 2025 · Precision medicine and engineering.
  56. Molecular Mechanisms of Respiratory Syncytial Virus Pathogenesis
    Madison J. Granoski, Aleksandra Stojic, Stephen Z. Lee, David Marchant · 2025 · Annual Review of Pathology Mechanisms of Disease
  57. Additional file 1 of Efficacy, immunogenicity and safety of respiratory syncytial virus prefusion F vaccine: systematic review and meta-analysis
    Pang, Yi, Lu, Haishan, Demin Cao, Xiaoying Zhu, Qinqin Long, Fengqin Tian, Long, Xidai, Li, Yulei · 2024 · Figshare
  58. Respiratory Syncytial Virus F Protein Adjuvanted with a Carbomer-Based Adjuvant Induces Protective Humoral Response in Mice
    Shivam Kumar Singh, Balwant Singh, Bhisma Narayan Panda, Thomas Cleven, Marulasiddappa R Suresh, Guruprasad R. Medigeshi · 2026 · ACS Omega
  59. Adenovector 26 Encoded RSV Prefusion F Protein (Ad26.RSV.preF) Does Not Predispose to Enhanced Respiratory Disease in Preclinical Rodent Models
    Renske Bolder, Susan B. S. King, Roland C. Zahn, Leslie van der Fits · 2026 · Vaccines
  60. An Integrative Biophysical Framework for Quantifying Conformational Dynamics in Complex Biomolecular Systems: Perspectives on Viral Glycoprotein Evolutionary Divergence
    Sami Rashid Mohammed Shibah · 2026 · SSRN Electronic Journal
  61. Revisiting Vaccine Innovation: A Critique of the “Generation Gold Standard” Initiative
    Yongxin Zhang · 2025 · Journal of Cellular Immunology
  62. De novo design of a safe and potent respiratory syncytial virus immuno-focusing antigen
    Woo Yeon Hwang, Jinung Song, Jiwon Choe, Keun Bon Ku, Hyung-Sun Kim, Gun Young Yoon, Do Yeon Kim, Mi‐Ra Choi, Eun‐Ji Kim, Jae Seung Lee et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  63. Optimally fixed F protein on the surface of RSV-infected cells for RSV binding and neutralizing assays
    Hongsheng Qiang, Yujin Shi, Zemin Jiang, Yuhao Fu, Xiaobin Zhang, Li Chen, Yongpeng Sun, Yangling Wu, Zizheng Zheng, Ningshao Xia · 2026 · Frontiers in Microbiology
  64. Innovative antiviral strategies: Clinical advances in respiratory syncytial virus inhibitor development
    Sundian Liu, Jinrong Hu, Kairui Kang, Meiyan Wei, Xintao Deng, Han Li, Zhiyou Yang · 2026 · Elsevier eBooks
  65. Structural vaccinology expedites rational design of next-generation vaccines for influenza and respiratory syncytial virus
    Lei Deng, Jiaye Liu, Yu Peng · 2026 · Virologica Sinica
  66. Étude de l'infection par le métapneumovirus humain : facteurs de virulence et développement de vaccins vivants atténués
    Julia Dubois · 2018
  67. Structural vaccinology applied to Hantaviruses
    Alexandra Serris · 2020
  68. Conception de médicaments contre le virus de la bronchiolite à partir d'une nouvelle cible thérapeutique
    Silva Khodjoyan · 2023 · theses.fr (ABES)
  69. Genomic surveillance in the UAE reveals the global origins and local diversification of RSV lineages
    Hao Zhou, Salwa Ali, Madikay Senghore, Amirtharaj Francis, Pamela Murad, Mahra Al Hosani, Faisal Al Ahbabi, Andreas Henschel, Farida Ismail Al Hosani, Dean Everett · 2026 · Research Square
  70. A fusion protein’s weak link: functional constraints revealed by inhibitory peptide interaction with the parainfluenza fusion protein
    Maximilian Crosby, Ariel J. Kuhn, Gillian Zipursky, Tara C. Marcink, Kyle N. Stearns, Elizabeth B. Sobolik, Dariia Vyshenska, Jee Ching Mook, Alexander L. Greninger, Matteo Porotto et al. · 2026 · mBio
  71. Novel Vaccine Development
    Tatsuo Shioda · 2026 · Springer eBooks
  72. Enhanced Th1 Cellular Immunity Induced by an RSV-F mRNA Vaccine Rationally Designed Using NLP Algorithms
    Zhi-Wu Xia, Qi Tang, Jun-Jie Pan, Jing Liu, Lan-Xin Jia, Guo-Mei Zhang, Man-Ni Xie, Jia-Hao Zheng, Chuan-Shuo Lv, Lei Zhang et al. · 2026 · Vaccines
  73. Enflonsia (clesrovimab) and the future of RSV lower respiratory tract disease prevention in neonates:[RETRACTED]
    Harshika Khaim Chandani, Syeda Fadak Zahra Hujjat, Devya Khaim Chandani, Muhammad S. Khan, Abubakr Mahmoud · 2026 · Annals of Medicine and Surgery · Retracted
  74. Comparative immunogenicity of monomeric and tetrameric Nipah virus G glycoprotein-based vaccine candidates demonstrate robust antibody responses in both forms
    Surbhi Mishra, Varun Kumar, Gurleen Kaur, Basil A Baby, Arpita Das, Ananya Chatterjee, Preeti Vishwakarma, Sangita Kumari Sinha, A T Rajesh Kumar, Vidya Mangala Prasad et al. · 2026 · Vaccine
  75. DARMN: Domain-Aware Residual Feature Modulation Network for Multidomain Protein Dynamic Inter-Residue Contact Prediction
    Jing Xiao, Wei Bu Wang, Yi Bo Ma, Ze Yuan Dong, Jiao Li, Ji Guo Su, Jingyuan Li · 2026 · Journal of Chemical Theory and Computation
  76. A novel prefusion and trimer-stabilized RSV F vaccine with robust immunogenicity and protection against respiratory syncytial virus
    Xinghua Che · 2026 · Research Square
  77. Cavity-Filling Mutations as a Strategy to Stabilize Prefusion Viral Fusion Proteins for Vaccine Design
    Reetesh Kumar, Pandiyan Muthuramalingam, Savitri Tiwari, Jyoti Gupta, Ramji Gupta, Prashant Agarwal, Himanshu Yadav, Nitish Kumar, Janhvi Mishra Rawat, Karthikeyan Ravi et al. · 2026 · Computational and Structural Biotechnology Journal
  78. Adult respiratory syncytial virus infection and community-acquired pneumonia: pathogenesis, diagnostic challenges and the clinical implications
    Seong‐Beom Park, Saeyong Lee, S.T. Shin, Jung Yeon Heo · 2026 · Expert Review of Vaccines
  79. A cavity-reduced prefusion RSV F bivalent vaccine elicits durable and protective immunity
    Lijie Liu, Mengrong Yan, Ruoxu Liang, Qingxin Wu, Changbin Qu, Huiqi Wu, Zhi Liao, Huiyu Chen, Jingjing Zou, Zeyun Sun et al. · 2026 · EMBO Molecular Medicine
  80. Plant-derived RSV pre-F with ER retention exhibits enhanced macrophages uptake and immune effects
    Hai‐Ping Diao, Jingrong Wang, Jianfeng Zhang, Yongfeng Guo, Inhwan Hwang, Shi‐Jian Song · 2026 · The Innovation Life
  81. Mechanistic blockade of RSV infection by a pre-F targeting single-domain antibody-Fc fusion protein
    Shuang Liu, Xiran Qiu, Shiyu Guo, Liying Wang, Hui Shen, Mao‐Mao An · 2026 · Antimicrobial Agents and Chemotherapy
  82. Distinct mechanisms of neutralization by antibodies targeting a conserved pneumovirus F epitope
    Sebastian Ols, Rodrigo Arcoverde Cerveira, Andrew J. Borst, Erick Bermúdez-Méndez, Florian A. Gegenfurtner, Elise Eray, Connor Weidle, Marcos C. Miranda, Zhitong Peng, Kenneth D. Carr et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  83. Punicalin targets RSV glycoprotein and fusion protein at non-overlapping sites to prevent viral escape
    Yingcai Xiong, Jingyi Ming, Zhaowei Zhang, Jiru Zhang, Xiaoqing Zhou, Biyu Cao, Guang Li, 朱宇清, Zepeng Yang, Junxi Song et al. · 2026 · Cell Reports Medicine
  84. From laboratory quantification to rapid on-site testing: Screening of high-affinity monoclonal antibody pairs targeting the RSV F protein and analytical evaluation across multiple assay platforms
    Siqin Peng, Qiqi Liu, Chen Duan, Junxi Liu, Rui Wang, Yingqi Huang, Anhai Long, Qiaoying Deng, Xiyan Deng, Ting Wan et al. · 2026 · Talanta